|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shrestha AD, Neupane D, Vedsted P and
Kallestrup P: Cervical cancer prevalence, incidence and mortality
in low and middle income countries: A systematic review. Asian Pac
J Cancer Prev. 19:319–324. 2018.PubMed/NCBI
|
|
3
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and
Bray F: Cancer incidence and mortality patterns in Europe:
Estimates for 40 countries in 2012. Eur J Cancer. 49:1374–1403.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Canfell K: Towards the global elimination
of cervical cancer. Papillomavirus Res. 8:1001702019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tano K and Akimitsu N: Long non-coding
RNAs in cancer progression. Front Genet. 3:2192012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hu Y, Chen HY, Yu CY, Xu J, Wang JL, Qian
J, Zhang X and Fang JY: A long non-coding RNA signature to improve
prognosis prediction of colorectal cancer. Oncotarget. 5:2230–2242.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu X, Tian X, Yu C, Shen C, Yan T, Hong
J, Wang Z, Fang JY and Chen H: A long non-coding RNA signature to
improve prognosis prediction of gastric cancer. Mol Cancer.
15:602016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li J, Wang W, Xia P, Wan L, Zhang L, Yu L,
Wang L, Chen X, Xiao Y and Xu C: Identification of a five-lncRNA
signature for predicting the risk of tumor recurrence in patients
with breast cancer. Int J Cancer. 143:2150–2160. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zaheed O, Samson J and Dean K: A
bioinformatics approach to identify novel long, non-coding RNAs in
breast cancer cell lines from an existing RNA-sequencing dataset.
Noncoding RNA Res. 5:48–59. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li M, Liu Y, Zhang X, Liu J and Wang P:
Transcriptomic analysis of high-throughput sequencing about
circRNA, lncRNA and mRNA in bladder cancer. Gene. 677:189–197.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang Y, Liao H, Zhang Y, Yuan R, Wang F,
Gao Y, Wang P and Du Z: Prognostic value of tumor-infiltrating
FoxP3+ T cells in gastrointestinal cancers: A meta analysis. PLoS
One. 9:e943762014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Huang Y and Qin M:
Tumour-infiltrating FoxP3+ and IL-17-producing T cells affect the
progression and prognosis of gallbladder carcinoma after surgery.
Scand J Immunol. 78:516–522. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bennett CL, Christie J, Ramsdell F,
Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT,
Chance PF and Ochs HD: The immune dysregulation,
polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused
by mutations of FOXP3. Nat Genet. 27:20–21. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peng GL, Li L, Guo YW, Yu P, Yin XJ, Wang
S and Liu CP: CD8(+) cytotoxic and FoxP3(+) regulatory T
lymphocytes serve as prognostic factors in breast cancer. Am J
Transl Res. 11:5039–5053. 2019.PubMed/NCBI
|
|
16
|
Li F, Sun Y, Huang J, Xu W, Liu J and Yuan
Z: CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are
predictive indictors of gastric cancer prognosis. Cancer Med.
8:7330–7344. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang S, Wu J, Ren J, Vlantis AC, Li MY,
Liu SYW, Ng EKW, Chan ABW, Luo DC, Liu Z, et al: MicroRNA-125b
interacts with Foxp3 to induce autophagy in thyroid cancer. Mol
Ther. 26:2295–2303. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang S, Liu Y, Li MY, Ng CSH, Yang SL,
Wang S, Zou C, Dong Y, Du J, Long X, et al: FOXP3 promotes tumor
growth and metastasis by activating Wnt/beta-catenin signaling
pathway and EMT in non-small cell lung cancer. Mol Cancer.
16:1242017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tanaka A and Sakaguchi S: Targeting Treg
cells in cancer immunotherapy. Eur J Immunol. 49:1140–1146.
2019.PubMed/NCBI
|
|
20
|
Luo Q, Zhang S, Wei H, Pang X and Zhang H:
Roles of Foxp3 in the occurrence and development of cervical
cancer. Int J Clin Exp Pathol. 8:8717–8730. 2015.PubMed/NCBI
|
|
21
|
Tang J, Yang Z, Wang Z, Li Z, Li H, Yin J,
Deng M, Zhu W and Zeng C: Foxp3 is correlated with VEGF-C
expression and lymphangiogenesis in cervical cancer. World J Surg
Oncol. 15:1732017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang Z, Kang B, Li C, Chen T and Zhang Z:
GEPIA2: An enhanced web server for large-scale expression profiling
and interactive analysis. Nucleic Acids Res. 47:W556–W560. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Z, Jensen MA and Zenklusen JC: A
practical guide to The Cancer Genome Atlas (TCGA). Methods Mol
Biol. 1418:111–141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
GTEx Consortium: The Genotype-Tissue
Expression (GTEx) project. Nat Genet. 45:580–585. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Di J, Rutherford S and Chu C: Review of
the cervical cancer burden and population-based cervical cancer
screening in China. Asian Pac J Cancer Prev. 16:7401–7407. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li H, Wu X and Cheng X: Advances in
diagnosis and treatment of metastatic cervical cancer. J Gynecol
Oncol. 27:e432016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim HJ, Lee DW, Yim GW, Nam EJ, Kim S, Kim
SW and Kim YT: Long non-coding RNA HOTAIR is associated with human
cervical cancer progression. Int J Oncol. 46:521–530. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang Y, Li Y, Fang S, Jiang B, Qin C, Xie
P, Zhou G and Li G: The role of MALAT1 correlates with HPV in
cervical cancer. Oncol Lett. 7:2135–2141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sun NX, Ye C, Zhao Q, Zhang Q, Xu C, Wang
SB, Jin ZJ, Sun SH, Wang F and Li W: Long noncoding RNA-EBIC
promotes tumor cell invasion by binding to EZH2 and repressing
E-cadherin in cervical cancer. PLoS One. 9:e1003402014. View Article : Google Scholar : PubMed/NCBI
|
